Literature DB >> 12871665

Prostanoid receptors and phosphatidylinositol 3-kinase: a pathway to cancer?

Hiromichi Fujino1, John W Regan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12871665     DOI： 10.1016/S0165-6147(03)00162-7

Source DB:  PubMed          Journal:  Trends Pharmacol Sci        ISSN： 0165-6147            Impact factor:   14.819


× No keyword cloud information.
  22 in total

1.  Roles of Eicosanoids in Prostate Cancer.

Authors:  Kasem Nithipatikom; William B Campbell
Journal:  Future Lipidol       Date:  2008-08-01

2.  Intracellular EP2 prostanoid receptor promotes cancer-related phenotypes in PC3 cells.

Authors:  Ana Belén Fernández-Martínez; Javier Lucio-Cazaña
Journal:  Cell Mol Life Sci       Date:  2015-04-01       Impact factor: 9.261

3.  COX-2 and prostaglandin EP3/EP4 signaling regulate the tumor stromal proangiogenic microenvironment via CXCL12-CXCR4 chemokine systems.

Authors:  Hiroshi Katoh; Kanako Hosono; Yoshiya Ito; Tatsunori Suzuki; Yasufumi Ogawa; Hidefumi Kubo; Hiroki Kamata; Toshiaki Mishima; Hideaki Tamaki; Hiroyuki Sakagami; Yukihiko Sugimoto; Shuh Narumiya; Masahiko Watanabe; Masataka Majima
Journal:  Am J Pathol       Date:  2010-01-28       Impact factor: 4.307

4.  15-Keto-PGE2 acts as a biased/partial agonist to terminate PGE2-evoked signaling.

Authors:  Suzu Endo; Akiko Suganami; Keijo Fukushima; Kanaho Senoo; Yumi Araki; John W Regan; Masato Mashimo; Yutaka Tamura; Hiromichi Fujino
Journal:  J Biol Chem       Date:  2020-07-29       Impact factor: 5.157

5.  Signaling via the prostaglandin E₂ receptor EP4 exerts neuronal and vascular protection in a mouse model of cerebral ischemia.

Authors:  Xibin Liang; Lu Lin; Nathaniel S Woodling; Qian Wang; Christoph Anacker; Tingting Pan; Milton Merchant; Katrin Andreasson
Journal:  J Clin Invest       Date:  2011-10-03       Impact factor: 14.808

6.  Prostaglandin E receptor EP1 suppresses breast cancer metastasis and is linked to survival differences and cancer disparities.

Authors:  Xinrong Ma; Namita Kundu; Olga B Ioffe; Olga Goloubeva; Raymond Konger; Claudia Baquet; Phyllis Gimotty; Jocelyn Reader; Amy M Fulton
Journal:  Mol Cancer Res       Date:  2010-09-21       Impact factor: 5.852

7.  Activation of the human FP prostanoid receptor disrupts mitosis progression and generates aneuploidy and polyploidy.

Authors:  X-B Chen; J W Regan
Journal:  Cell Mol Life Sci       Date:  2006-01       Impact factor: 9.261

8.  PGF2α-F-prostanoid receptor signalling via ADAMTS1 modulates epithelial cell invasion and endothelial cell function in endometrial cancer.

Authors:  Margaret C Keightley; Kurt J Sales; Henry N Jabbour
Journal:  BMC Cancer       Date:  2010-09-14       Impact factor: 4.430

Review 9.  Prostanoid receptor antagonists: development strategies and therapeutic applications.

Authors:  R L Jones; M A Giembycz; D F Woodward
Journal:  Br J Pharmacol       Date:  2009-07-15       Impact factor: 8.739

10.  Selective EP2 and Cox-2 inhibition suppresses cell migration by reversing epithelial-to-mesenchymal transition and Cox-2 overexpression and E-cadherin downregulation are implicated in neck metastasis of hypopharyngeal cancer.

Authors:  Yoshihiro Watanabe; Yorihisa Imanishi; Hiroyuki Ozawa; Koji Sakamoto; Ryoichi Fujii; Seiji Shigetomi; Noboru Habu; Kuninori Otsuka; Yoichiro Sato; Mariko Sekimizu; Fumihiro Ito; Yuichi Ikari; Shin Saito; Kaori Kameyama; Kaoru Ogawa
Journal:  Am J Transl Res       Date:  2020-03-15       Impact factor: 4.060
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.